Latest News of AADI
Aadi Bioscience to Halt Tumor Treatment Trial, Preserve Cash Flow With Job Cuts
By MarketWatch |
3 months ago
Aadi Bioscience will stop a tumor treatment trial due to lack of efficacy. The company will now focus on conserving cash by pausing other trials and reducing its research staff by 80%, aiming to prolo...
We're Keeping An Eye On Aadi Bioscience's (NASDAQ:AADI) Cash Burn Rate
By Yahoo! Finance |
3 months ago
Investors are attracted to unprofitable companies like Aadi Bioscience due to growth potential. However, increasing cash burn and funding difficulties raise concerns. Analyst forecasts and risks shoul...